OverviewChartNewsTraderScreen

OPEN END TURBO C AUF DAVITA/  DE000HG6MGK2  /

Frankfurt Zertifikate
2024-05-15  12:35:33 PM Chg.+0.040 Bid12:43:50 PM Ask12:36:45 PM Underlying Strike price Expiration date Option type
7.680EUR +0.52% -
Bid Size: -		 -
Ask Size: -		 DaVita Inc 54.778 - 2078-12-31 Call
GlobeNewswire 05-07 Nuwellis, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire 04-26 Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire 04-23 Garry Menzel joins GHO Capital as Operating Partner
GlobeNewswire 04-23 Garry Menzel joins GHO Capital as Operating Partner
GlobeNewswire 04-09 FullBloom Expands Leadership Team with Key Appointments
GlobeNewswire 03-05 Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-19 Ibotta Expands Senior Leadership Team, Adds Seasoned CLO David Shapiro
TeleTrader 02-14 US opens higher amid earnings reports
GlobeNewswire 01-04 Sigyn Therapeutics Releases Letter to Shareholders
GlobeNewswire 2023-11-17 Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
TeleTrader 2023-11-08 US opens higher ahead of Fed speeches, earnings
GlobeNewswire 2023-11-07 Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
TeleTrader 2023-09-13 US closes mostly higher after inflation report
GlobeNewswire 2023-08-15 Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire 2022-03-21 Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
Newsfile Corp 2022-03-16 OrbVest Announces the Acquisition of the Cincinnati Medical Office
GlobeNewswire 2022-03-07 The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire 2022-02-10 Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire 2021-12-07 Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
GlobeNewswire 2021-10-21 Renalytix Reports Full Year Fiscal 2021 Results
GlobeNewswire 2021-10-07 Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire 2021-10-01 AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire 2021-09-09 ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire 2021-09-09 Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development
GlobeNewswire 2021-08-11 Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and ...